Breaking Finance News

HealthSouth Corp (NYSE:HLS) has been upgraded to Buy in a statement by ValuEngine earlier today.

ValuEngine has upgraded HealthSouth Corp (NYSE:HLS) to Buy in a statement released on 7/7/2017.

Having a price of $47.35, HealthSouth Corp (NYSE:HLS) traded 0.00% even on the day. With the last close up -1.28% from the two hundred day average, compared with the S&P 500 Index which has increased 0.05% over the same period. HealthSouth Corp has recorded a 50-day average of $45.71 and a two hundred day average of $44.16. Volume of trade was down over the average, with 425,155 shares of HLS changing hands under the typical 957,384

Performance Chart

HealthSouth Corp (NYSE:HLS)

With a total market value of $0, HealthSouth Corp has price-earnings ratio of 15.89 with a one year low of $36.97 and a one year high of $49.71 .

A total of 11 firms have issued a report on the stock. 2 brokers rating the stock a strong buy, six equity analysts rating the company a buy, three equity analysts rating the company a hold, one analyst rating the company a underperform, and finally zero analysts rating the company a sell with a one year target of $44.45.

More About HealthSouth Corp (NYSE:HLS)

HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice. It is an owner and operator of inpatient rehabilitation hospitals. It provides specialized rehabilitative treatment on both an inpatient and outpatient basis. It offers its home health and hospice services through Encompass Home Health and Hospice business (Encompass). Encompass operates home health and hospice agencies in 25 states, with concentrations in the Southeast, Oklahoma, and Texas. As of December 31, 2016, the Company operated 123 inpatient rehabilitation hospitals. As of December 31, 2016, the Company managed five inpatient rehabilitation units through management contracts.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.